Publications by authors named "Bonnie S Glisson"

95Publications

A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.

Oncologist 2020 Jul 1. Epub 2020 Jul 1.

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2020-0610DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543335PMC
July 2020

Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma.

Oral Oncol 2020 02 19;101:104523. Epub 2019 Dec 19.

Department of Thoracic, Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2019.104523DOI Listing
February 2020

PI3-kinase pathway biomarkers in oral cancer and tumor immune cells.

Head Neck 2019 03 16;41(3):615-622. Epub 2018 Dec 16.

The University of Texas MD Anderson Cancer Center, Department of Thoracic/Head and Neck Medical Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.25350DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382518PMC
March 2019

New Hope for Therapeutic Cancer Vaccines in the Era of Immune Checkpoint Modulation.

Annu Rev Med 2019 01 31;70:409-424. Epub 2018 Oct 31.

Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-050217-121900DOI Listing
January 2019

Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma.

Br J Ophthalmol 2019 06 18;103(6):775-780. Epub 2018 Jul 18.

Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bjophthalmol-2018-312277DOI Listing
June 2019

Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models.

Oncogene 2018 07 6;37(27):3686-3697. Epub 2018 Apr 6.

Thoracic Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-018-0187-2DOI Listing
July 2018

Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial.

Cancer 2018 05 26;124(10):2169-2173. Epub 2018 Mar 26.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935588PMC
May 2018

Outcomes for olfactory neuroblastoma treated with induction chemotherapy.

Head Neck 2017 08 31;39(8):1671-1679. Epub 2017 May 31.

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.24822DOI Listing
August 2017

Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.

J Clin Oncol 2017 Jan 21;35(3):352-360. Epub 2016 Nov 21.

Renata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, Irene Guijarro, Jing Wang, Patrick Zweidler-McKay, Diana Bell, William N. William Jr, Bonnie S. Glisson, J. Jack Lee, Andrew Futreal, Adel K. El-Naggar, and John V. Heymach, University of Texas MD Anderson Cancer Center, Houston; Michael J. Wick and Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Ann M. Kapoun, Leonardo Faoro, and Jakob Dupont, OncoMed Pharmaceuticals, Redwood City; Pamela Munster, University of California San Francisco, San Francisco, CA; and Gail Eckhardt, University of Colorado Denver School of Medicine, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.5264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5456373PMC
January 2017

MYB-fusions and other potential actionable targets in adenoid cystic carcinoma.

Curr Opin Oncol 2016 May;28(3):195-200

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000280DOI Listing
May 2016

Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy.

Head Neck 2016 04 27;38 Suppl 1:E2091-9. Epub 2016 Feb 27.

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.24387DOI Listing
April 2016

New Strategies in Human Papillomavirus-Related Oropharynx Cancer: Effecting Advances in Treatment for a Growing Epidemic.

Clin Cancer Res 2015 Sep;21(17):3821-8

Department of Thoracic and Head/Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1329DOI Listing
September 2015

Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancers.

Anticancer Drugs 2015 Sep;26(8):835-42

Departments of aThoracic/Head & Neck Medical Oncology bHead and Neck Surgery, The University of Texas MD Anderson Cancer Center cThe University of Texas Graduate School of Biomedical Sciences, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515205PMC
September 2015

Small cell lung carcinoma: staging, imaging, and treatment considerations.

Radiographics 2014 Oct;34(6):1707-21

From the Department of Diagnostic Radiology, Division of Diagnostic Imaging (B.W.C., M.T.T., J.J.E.), and Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine (B.S.G.), University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1478, Houston, TX 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.346140178DOI Listing
October 2014

A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma.

Mol Cancer Ther 2014 Nov 5;13(11):2738-50. Epub 2014 Sep 5.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-13-1090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221385PMC
November 2014

Is there still a role for induction chemotherapy in locally advanced head and neck cancer?

Curr Opin Oncol 2014 May;26(3):247-51

aDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA bMedical Oncology, Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000073DOI Listing
May 2014

Phase II study of gefitinib in patients with advanced salivary gland cancers.

Head Neck 2015 May 30;37(5):644-9. Epub 2015 Mar 30.

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; Hematology/Medical Oncology Division, Northeast Ohio Medical University, Medina, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.23647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669372PMC
May 2015

Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway.

J Natl Cancer Inst 2013 Oct 3;105(20):1558-70. Epub 2013 Oct 3.

Affiliations of authors: Department of Thoracic/Head and Neck Medical Oncology (DHS, SPC, FMJ, SML, BSG) and Department of Experimental Therapeutics (KM), The University of Texas MD Anderson Cancer Center, Houston, TX; College of Pharmacy, Inje University, Gimhae, Gyungnam, Republic of Korea (H-JL); College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea (H-YM, M-SL, JWL, H-YL).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797025PMC
October 2013

The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer.

Cancer 2013 Sep 3;119(17):3162-9. Epub 2013 Jun 3.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775996PMC
September 2013

A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck.

Clin Cancer Res 2012 Mar 18;18(5):1435-46. Epub 2012 Jan 18.

Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167936PMC
March 2012

Large-cell neuroendocrine carcinoma: controversies in diagnosis and treatment.

J Natl Compr Canc Netw 2011 Oct;9(10):1122-9

Departments of aThoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2011.0093DOI Listing
October 2011

Novel strategies for the treatment of small-cell lung carcinoma.

Nat Rev Clin Oncol 2011 Jun 21;8(10):611-9. Epub 2011 Jun 21.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 432, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2011.90
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2011.90DOI Listing
June 2011

Targeting an autocrine loop in small-cell lung cancer: irrelevant target or ineffective drug?

Authors:
Bonnie S Glisson

Clin Lung Cancer 2010 Jul;11(4):222

The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2010.n.027DOI Listing
July 2010

Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma.

Cancer 2010 May;116(10):2409-15

Department of Thoracic Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25076DOI Listing
May 2010

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

J Clin Oncol 2010 Jan 16;28(1):8-14. Epub 2009 Nov 16.

Departments of Thoracic/Head and Neck Medical Oncology, Head and Neck Surgery, Radiation Oncology, Biostatistics, Radiology, and Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.23.0425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799235PMC
January 2010

A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck.

Am J Clin Oncol 2009 Jun;32(3):274-9

Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e318187dd57DOI Listing
June 2009

Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.

Int J Radiat Oncol Biol Phys 2009 Jan 14;73(1):119-27. Epub 2008 Jun 14.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.03.069DOI Listing
January 2009

Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study.

Cancer 2008 Jun;112(12):2698-709

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23486DOI Listing
June 2008

Dose-dependent and sequence-dependent cytotoxicity of erlotinib and docetaxel in head and neck squamous cell carcinoma.

Anticancer Drugs 2008 Jun;19(5):465-75

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001813-200806000-000
Publisher Site
http://dx.doi.org/10.1097/CAD.0b013e3282fc46c4DOI Listing
June 2008

Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer.

J Thorac Oncol 2007 Aug;2(8):745-50

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641531305
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e31811f4719DOI Listing
August 2007

Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.

Cancer 2006 Jan;106(2):366-74

Department of Thoracic Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21640DOI Listing
January 2006

A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.

Int J Radiat Oncol Biol Phys 2005 Nov;63(3):717-24

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2005.03.001DOI Listing
November 2005

Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series.

Head Neck 2005 Sep;27(9):748-56

Department of Head and Neck Surgery, Unit 441, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.20240DOI Listing
September 2005

Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors.

Cancer 2004 May;100(10):2240-5

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20238DOI Listing
May 2004

Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?

Cancer 2004 Mar;100(6):1171-8

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20069DOI Listing
March 2004

Management of nonsinonasal neuroendocrine carcinomas of the head and neck.

Cancer 2003 Dec;98(11):2322-8

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11795DOI Listing
December 2003

Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer.

Oncology (Williston Park) 2003 Jul;17(7 Suppl 7):17-21

Division of Cancer Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
July 2003

A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer.

Clin Cancer Res 2003 Jun;9(6):2085-91

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
June 2003

Recurrent small cell lung cancer: update.

Authors:
Bonnie S Glisson

Semin Oncol 2003 Feb;30(1):72-8

Department of Thoracic, Head & Neck Medical Oncology, University of Texas M.D. Anderson Cancer, Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonc.2003.50014DOI Listing
February 2003

Treatment of metastatic head and neck cancer: chemotherapy and novel agents.

Cancer Treat Res 2003 ;114:295-314

University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/0-306-48060-3_12DOI Listing
May 2003

The role of docetaxel in the management of squamous cell cancer of the head and neck.

Authors:
Bonnie S Glisson

Oncology (Williston Park) 2002 Jun;16(6 Suppl 6):83-7

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.

View Article

Download full-text PDF

Source
June 2002

Direct correlation between FRA3B expression and cigarette smoking.

Genes Chromosomes Cancer 2002 Jul;34(3):333-40

Departments of Pathology and Pediatrics, State University of New York Upstate Medical University, Syracuse, NY 13210, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/gcc.10061
Publisher Site
http://dx.doi.org/10.1002/gcc.10061DOI Listing
July 2002

Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.

J Clin Oncol 2002 Jan;20(2):364-70

Department of Thoracic/Head and Neck Medical Oncology, Diagnostic Imaging, Biostatistics, Head and Neck Surgery, and Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.20.2.364DOI Listing
January 2002